Lumawan, Kerian Von A.
HRN: 21-34-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/10/2022
05/17/2022
IVT
13mg
Q24H
Bacterial Skin Infection; T/C Infected Pustulosis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes